An international team led by CFRI member Dr. Christopher Maxwell and his colleague Dr. Miguel Àngel Pujana of the Catalan Institute of Oncology describes a fundamental molecular mechanism in the development of breast cell epithelium that is altered in some breast cancer patients. Researchers have found a key in the interplay between two genes which represents a previously unknown molecular pathway. The results were published this week in the journal PLoS Biology.
Scientists have developed a molecular “clock” that could reshape how pediatricians measure and monitor childhood growth and potentially allow for an earlier diagnosis of life-altering development disorders. The research, published this week in PNAS, describes how the addition of chemical tags to DNA over time can potentially be used to screen for developmental differences and health problems in children.